WASHINGTON, Aug 22: Scientists have created a new human embryonic stem cell from an ordinary skin cell, US researchers said on Monday. They hope their method, which fuses an embryonic stem cell to an ordinary skin cell and bone cells, could someday provide tailor-made medical treatments without having to start from scratch using cloning technology.
That would also mean generating the valuable cells without using a human egg, and without creating a human embryo, which some people, including President George W. Bush, oppose.
But the team, led by stem cell experts Kevin Eggan, Dr. Douglas Melton and others at Harvard Medical School, stresses in a report to be published in next Friday’s issue of the journal Science that their method is not yet ready to try in humans.
“This technique is not ready for prime time now,” Eggan told reporters in a telephone briefing, adding that he feels cloning technology, the use of discarded embryos from fertility clinics and other approaches are all still vital.
Stem cells are the body’s master cells, used to continually regenerate tissues, organs and blood. Those taken from days-old embryos are considered the most versatile. They can produce any kind of tissue in the body.
Doctors hope to someday use embryonic stem cells as a source of perfectly matched transplants to treat diseases such as cancer, Parkinson’s and some injuries. Biologists want to study them to understand the basic causes of disease and development.
But because some people object to the destruction of or experimentation on a human embryo, US law restricts the use of federal funds for this kind of research.
It is a hot debate in Congress and several bills have been offered for consideration when the Senate comes back next month that would either relax the federal restrictions or tighten them even more.
“There still could be some groups of people that would object to (our method) because at one time the cells were derived from a very early human embryo,” Eggan said.
His team worked with stem cells created using both private and federal funding.
They fused embryonic stem cells to human adult skin cells, and managed to re-programme them back to an embryonic state. The new cells acted like stem cells, forming tumours called teratomas when injected into mice — a classic test for a true embryonic stem cell.
They also contained genes unique to stem cells.
The cells also appeared to survive indefinitely in a lab dish, another test of a true embryonic stem cell.
And when cultured in lab dishes, the cells differentiated, or matured, into the three major basic types of cell.
“Our motivation is completely based in science,” Eggan said.
“Myself and my colleagues feel very, very strongly that research with somatic cell nuclear transfer (so-called therapeutic cloning) should move forward. We feel it is critical.”—Reuters
